x
  • Search Result for

US Infusion Services Market Size and Forecast by Offering, Therapy Type, Administration Route, and Reimbursement Model: 2019-2033

  Feb 2026   | Format: PDF DataSheet |   Pages: 110+ | Type: Niche Industry Report |    Authors: Prayag Singh (Asst. Manager)  

 

US Infusion Services Market Outlook

  • In 2025, the US recorded USD 150.72 billion in revenue.
  • Data-driven estimates suggest the US Infusion Services Market is projected to expand to USD 278.61 billion in 2033, with a CAGR of 8.0% during the forecast horizon.
  • Hospital outpatient departments remain the dominant infusion setting, yet Medicare payment updates and 340B policy scrutiny are tightening margin visibility, prompting consolidation among oncology-focused infusion operators.
  • IQVIA and the American Cancer Society report rising biologic therapy utilization in oncology, supporting long-term infusion volume growth across commercial and Medicare populations.
  • DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation. [Learn more]

Market Scope Framework

Offering

  • Facility-Based Infusion Services
  • Home Infusion Therapy Services
  • Office-Based Physician Infusion Services
  • Specialty Biologic Administration Programs
  • Chronic Therapy Infusion Management Programs

Therapy Type

  • Oncology Infusions
  • Autoimmune and Inflammatory Therapy
  • Anti-Infective Therapy
  • Nutritional and Metabolic Infusion
  • Neurology and Rare Disease Infusion

Administration Route

  • Intravenous (IV)
  • Subcutaneous
  • Epidural / Intrathecal
  • Intra-Arterial

Reimbursement Model

  • Fee-for-Service
  • Bundled Episode-Based
  • Capitated / Risk-Based
  • Hybrid Contracting
×

Request Sample

CAPTCHA Refresh